{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:49:23Z","timestamp":1754153363555,"version":"3.41.2"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1097\/igc.0b013e318251cb47","type":"journal-article","created":{"date-parts":[[2012,4,25]],"date-time":"2012-04-25T04:25:47Z","timestamp":1335327947000},"page":"S18-S20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"S1","title":["The UKCTOCS Experience\u2014Reasons for Hope?"],"prefix":"10.1016","volume":"22","author":[{"given":"Usha","family":"Menon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jatinderpal","family":"Kalsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e318251cb47_bb0005","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1006\/gyno.2000.5816","article-title":"The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer","volume":"77","author":"van Nagell","year":"2000","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e318251cb47_bb0010","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0140-6736(98)10261-1","article-title":"Screening for ovarian cancer: a pilot randomised controlled trial","volume":"353","author":"Jacobs","year":"1999","journal-title":"Lancet."},{"key":"10.1097\/IGC.0b013e318251cb47_bb0015","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/1097-0142(20000801)89:3<582::AID-CNCR13>3.0.CO;2-#","article-title":"Usefulness of mass screening for ovarian carcinoma using transvaginal ultrasonography","volume":"89","author":"Sato","year":"2000","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e318251cb47_bb0020","doi-asserted-by":"crossref","unstructured":"Menon U, Gentry-Maharaj A, Ryan A, et al. Recruitment to multicentre trialsVlessons from UKCTOCS: descriptive study. BMJ. 2008;337:a2079. doi: 10.1136\/bmj.a2079. Erratum in: BMJ. 2008; 337:a2976.","DOI":"10.1136\/bmj.a2976"},{"key":"10.1097\/IGC.0b013e318251cb47_bb0025","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1470-2045(09)70026-9","article-title":"Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)","volume":"10","author":"Menon","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1097\/IGC.0b013e318251cb47_bb0030","doi-asserted-by":"crossref","unstructured":"Skates SS, Menon U, MacDonald N, et al. Calculation of the risk of ovarian cancer from serial ca-125 values for preclinical detection in postmenopausal women. J. Clin Oncol. 2003;21:206s\u2013210s. May 15 supplement.","DOI":"10.1200\/JCO.2003.02.955"},{"key":"10.1097\/IGC.0b013e318251cb47_bb0035","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2011.766","article-title":"Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial","volume":"305","author":"Buys","year":"2011","journal-title":"JAMA."},{"key":"10.1097\/IGC.0b013e318251cb47_bb0040","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","article-title":"Molecular pathogenesis and extraovarian origin of epithelial ovarian cancerVshifting the paradigm","volume":"42","author":"Kurman","year":"2011","journal-title":"Hum Pathol."},{"key":"10.1097\/IGC.0b013e318251cb47_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000114","article-title":"The preclinical natural history of serous ovarian cancer: defining the target for early detection","volume":"6","author":"Brown","year":"2009","journal-title":"PLoS Med."},{"key":"10.1097\/IGC.0b013e318251cb47_bb0050","doi-asserted-by":"crossref","first-page":"109ra116","DOI":"10.1126\/scitranslmed.3003110","article-title":"Mathematical model identifies blood biomarker-based early cancer detection strategies and limitations","volume":"3","author":"Hori","year":"2011","journal-title":"Sci Transl Med."},{"key":"10.1097\/IGC.0b013e318251cb47_bb0055","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1097\/IGC.0b013e318251ca4e","article-title":"Inherited risk of ovarian cancer and the implications for screening","author":"Gayther","year":"2012","journal-title":"Int J Gynecol Cancer Suppl."},{"key":"10.1097\/IGC.0b013e318251cb47_bb0060","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1097\/IGC.0b013e318251caaf","article-title":"The potential for risk stratification in the management of ovarian cancer risk","author":"Pharoah","year":"2012","journal-title":"Int J Gynecol Cancer Suppl."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24155521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24155521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:18:15Z","timestamp":1753233495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24155521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":12,"alternative-id":["S1048891X24155521"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e318251cb47","relation":{},"ISSN":["1048-891X"],"issn-type":[{"type":"print","value":"1048-891X"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The UKCTOCS Experience\u2014Reasons for Hope?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e318251cb47","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2012 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}